SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-21-001051
Filing Date
2021-08-27
Accepted
2021-08-27 17:26:53
Documents
3
Group Members
CHRISTOPHER ROHDEFACTOR BIOSCIENCE LLCMATTHEW ANGELNOVELLUS LLC

Document Format Files

Seq Description Document Type Size
1 schedule13g.htm SC 13G 88935
2 exhibit99-1.htm EX-99.1 3782
3 exhibit99-2.htm EX-99.2 964
  Complete submission text file 0000929638-21-001051.txt   95623
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Subject) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-42217 | Film No.: 211220162
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8 MUSEUM WAY #204 CAMBRIDGE MA 02141
Business Address 8 MUSEUM WAY #204 CAMBRIDGE MA 02141 (781) 640-1031
Factor Bioscience Inc. (Filed by) CIK: 0001878775 (see all company filings)

IRS No.: 452567562 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G